Clinical Trials

320 enrolled

Breast

Breast Neoplasms

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

30 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT03573960 2026-03-06

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Phase 4 Completed

50 enrolled

Head & Neck

Thyroid Neoplasms

NCT04877522 2026-03-06

Asciminib Roll-over Study

MyeloidOther hematologic neoplasm

347 enrolled

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06862219 2026-03-06

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Genitourinary

Carcinoma, Transitional Cell

NCT07176689 2026-03-03

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

50 enrolled

Sarcoma

Desmoid Tumors

NCT07221838 2026-03-03

OCTAGON

75 enrolled

Adrenal Insufficiency, Myasthenia Gravis

NCT06457503 2026-03-02

TRANSPARENT

Head & Neck

Nasopharyngeal Neoplasms

NCT06876649 2026-03-02

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

LymphoidOther hematologic neoplasm

787 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06562543 2026-02-27

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

78 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06651970 2026-02-23

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

LymphoidOther hematologic neoplasm

60 enrolled

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

NCT03975829 2026-02-13

Pediatric Long-Term Follow-up and Rollover Study

163 enrolled

CNSMyeloid

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT07218341 2026-02-10

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

LymphoidOther hematologic neoplasm

150 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02584933 2026-02-03

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

233 enrolled

Tumor-Agnostic

Neoplasms

NCT03340506 2026-02-03

Dabrafenib and/or Trametinib Rollover Study

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT05252585 2026-02-03

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

4 enrolled

Tuberous Sclerosis, Angiomyolipoma

NCT01742299 2026-02-02

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

155 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05161195 2026-02-02

Roll-over Study to Allow Continued Access to Ribociclib

134 enrolled

Breast

Breast Neoplasms

NCT05348876 2026-01-30

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

50 enrolled

Genitourinary

Prostatic Neoplasms

NCT06057402 2026-01-27

MagnetisMM15

80 enrolled

Plasma cell

Multiple Myeloma

NCT04373564 2026-01-22

ODYSSEY

BreastEndocrineGastrointestinalGenitourinaryNET

2,076 enrolled

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT07357597 2026-01-22

TROPION-SWISH

Stomatitis

NCT07044687 2026-01-12

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05457257 2025-12-19

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

Phase 4 Completed

43 enrolled 16 charts

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06752850 2025-12-19

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Classical hematologyLymphoid

37 enrolled

Hemophilia A, Lymphoma, Follicular, Synovitis

NCT07169331 2025-12-19

A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia

18 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

NCT05144997 2025-12-17

Lorlatinib Continuation Study

76 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06538480 2025-12-15

Zopa Retreatment and Vector Shedding in Adults With RRP

30 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT07279935 2025-12-12

REVIVE